-
BTIG Reiterates Buy Rating on Spectral AI (MDAI)
-
Spectral AI, Inc. (MDAI) Raises up to $15M of Debt Financing and Strengthens Financial Position for U.S. Commercialization
-
H.C. Wainwright Reiterates Buy Rating on Spectral AI (MDAI)
-
Northland Reiterates Outperform Rating on Spectral AI (MDAI)
-
Spectral AI (MDAI) Announces Successful Results from its Burn Validation Study of the DeepView System
-
Spectral AI, Inc. (MDAI) Completes Three Device Installations in Australia
-
Spectral AI, Inc. (MDAI) Strengthens Financial Position Ahead of FDA Submission
-
Spectral AI, Inc. (MDAI) Completes Data Analysis for U.S. Burn Pivotal Study
-
Spectral AI, Inc. (MDAI) Completes Pediatric Enrollment in Emergency Departments for U.S. Burn Pivotal Study
-
Spectral AI (MDAI) Provides Update to Investors
-
Spectral AI, Inc. (MDAI) Provides Instructions for Retail Investors on Exercising Publicly-Traded Warrants
-
Spectral AI, Inc. (MDAI) Regains Nasdaq Compliance
-
Spectral AI (MDAI) Comments on Compliance with Nasdaq Listing Rule 5550(b)(2)
-
Spectral AI, Inc. (MDAI) Completes Truthing of Burn Center Images, Initiates Emergency Department Image Review
-
Spectral AI, Inc. (MDAI) Reprices Public Warrants
-
Spectral AI, Inc. (MDAI) Raises Up to $5 Million Financing Strengthening Financial Position for FDA Pathway
-
Spectral AI (MDAI) Announces Plan to Spin Off Spectral IP Subsidiary Focused on Intellectual Property Investments and Monetization
-
Spectral AI (MDAI) Announces Last Patient Out in U.S. Burn Pivotal Study at Burn Centers
-
Spectral AI, Inc. (MDAI) Files for $50M Share Offering
-
Spectral AI, Inc. (MDAI) Announces Return of Founder Dr. J. Michael DiMaio as Chairman of the Board of Directors
-
Spectral AI, Inc. (MDAI) Completes Proof of Concept for Wound Measurement Technology
-
Spectral AI (MDAI) Achieves 25% Patient Enrollment at Emergency Departments for U.S. Burn Pivotal Study and Adds Two New Clinical Trial Sites
-
Spectral AI (MDAI) Outlines U.S. Regulatory Pathway for DeepView System for Burn Indication
-
Spectral AI, Inc. (MDAI) Awarded Additional Funding from Medical Technology Enterprise Consortium
-
Spectral AI (MDAI) Announces Total U.S. and International Patent Portfolio Now Stands at 26 Granted Patents and 38 Pending Applications in Support of its AI-Driven DeepView System
-
Spectral AI (MDAI) Continues Support of Naked Short Selling Inquiry
-
Spectral AI, Inc. (MDAI) Announces Collaboration with PolyNovo
-
Spectral AI (MDAI) Expands Clinical Trial Sites for Pivotal U.S. Burn Study
-
Spectral AI, Inc. (MDAI) Supports Naked Short Selling Inquiry

